Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Inherited Retinal Disease > Study evaluates factors influencing bleb propagation in subretinal gene therapy for IRD
  • Inherited Retinal Disease

Study evaluates factors influencing bleb propagation in subretinal gene therapy for IRD

Ophthalmology 360

The formation and propagation of blebs in subretinal gene therapy for IRDs can be predicted based on factors such as patient age, retinotomy location, disease indication, and the direction of fluid injected into the subretinal space, according to a study.

This retrospective review of all subretinal gene therapy procedures performed between September 2018 and March 2020, included 70 eyes of the 46 patients with IRD.

The results demonstrated that the desired injection volumes and foveal treatment were successfully achieved in all eyes, regardless of the specific indication for IRD. However, the researchers found that bullous foveal detachment was associated with retinotomy performed closer to the fovea, posterior bleb bias, and greater bleb volumes.

The study also found that blebs exhibited anterior or posterior bias based on the specific disease indication and patient age. Retinotomy locations within 3.7mm (approximately 2 disc diameters) from the fovea were found to favor foveal detachment. The use of multiple retinotomies and blebs allowed for greater surface area coverage in some cases, but intersecting blebs did not propagate further.

Reference
Sisk RA, Berger TA, Williams ER, et al. Intraoperative Bleb Behavior in Subretinal Gene Augmentation Therapy for Inherited Retinal Diseases. Retina. 2023 Jun 8. doi: 10.1097/IAE.0000000000003857. Epub ahead of print. PMID: 37315516.

Share

Related Content

  • Inherited Retinal Disease

Survey finds variation in inherited retinal disease care among U.S. retina specialists

  • Inherited Retinal Disease

Patients with inherited retinal diseases face elevated risk of multiple ocular complications

  • Inherited Retinal Disease

Low-dose atropine shows limited effect on myopia progression in children with IRDs

  • Inherited Retinal Disease

Emerging imaging technologies offer hope for inherited retinal disease management

  • Inherited Retinal Disease

Emerging therapies and treatment for rare retinal diseases: a look at the pipeline

  • Inherited Retinal Disease

Breakthroughs in Gene Therapy and Diagnostics: Advancing Treatments and Understanding

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon